{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:05:07Z","timestamp":1765994707022,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ijcha.2020.100524","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T08:21:27Z","timestamp":1589530887000},"page":"100524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS\/PCI: A critical appraisal"],"prefix":"10.1016","volume":"28","author":[{"given":"Mattia","family":"Galli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicita","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"D'Amario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Vergallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco A.","family":"Montone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Niccoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ijcha.2020.100524_b0005","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"9872","key":"10.1016\/j.ijcha.2020.100524_b0010","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"The Lancet."},{"issue":"16","key":"10.1016\/j.ijcha.2020.100524_b0015","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting Stent implantation: The ISAR-TRIPLE trial","volume":"65","author":"Fiedler","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.ijcha.2020.100524_b0020","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.ijcha.2020.100524_b0025","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10206","key":"10.1016\/j.ijcha.2020.100524_b0030","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.ijcha.2020.100524_b0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.118.034722","article-title":"Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: A north American perspective\u20132018 update","volume":"138","author":"Angiolillo","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcha.2020.100524_b0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/europace\/euy174","volume":"21","author":"Lip","year":"2019","journal-title":"Europace."},{"year":"2019","author":"Potpara","journal-title":"EP Europace","key":"10.1016\/j.ijcha.2020.100524_b0045"},{"key":"10.1016\/j.ijcha.2020.100524_b0050","article-title":"Dual Therapy with DOACs significantly increases the risk of Stent Thrombosis compared to Triple Therapy","author":"Galli","year":"2019","journal-title":"Eur. Heart J. Cardiovasc Pharmacother."},{"year":"2019","author":"Gargiulo","journal-title":"Eur. Heart J.","key":"10.1016\/j.ijcha.2020.100524_b0055"},{"issue":"4","key":"10.1016\/j.ijcha.2020.100524_b0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ehjcvp\/pvz021","article-title":"Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis","volume":"5","author":"Haller","year":"2019","journal-title":"Eur. Heart J. \u2013 Cardiovascul. Pharmacother."},{"issue":"4","key":"10.1016\/j.ijcha.2020.100524_b0065","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/europace\/euz345","volume":"22","author":"Galli","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.ijcha.2020.100524_b0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijcard.2019.12.054","article-title":"Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials","volume":"302","author":"Ando","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcha.2020.100524_b0075","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/M19-3763","article-title":"Dual versus triple therapy for atrial fibrillation after percutaneous coronary intervention: A systematic review and meta-analysis","volume":"172","author":"Khan","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcha.2020.100524_b0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2015.02.004","article-title":"Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease","volume":"184","author":"Rohla","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcha.2020.100524_b0085","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijcard.2015.11.090","article-title":"Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?","volume":"203","author":"Ancedy","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcha.2020.100524_b0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2017.05.119","article-title":"Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review","volume":"243","author":"Chang","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"23","key":"10.1016\/j.ijcha.2020.100524_b0095","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1161\/CIRCULATIONAHA.119.043308","article-title":"Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial","volume":"140","author":"Windecker","year":"2019","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcha.2020.100524_b0100","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCULATIONAHA.119.044584","article-title":"Stent thrombosis in patients with atrial fibrillation undergoing coronary stenting in the AUGUSTUS trial","volume":"141","author":"Lopes","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcha.2020.100524_b0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ehjcvp\/pvz017","article-title":"Critical appraisal of the AUGUSTUS trial","volume":"5","author":"Gremmel","year":"2019","journal-title":"Eur. Heart J. \u2013 Cardiovascul. Pharmacother."},{"issue":"3","key":"10.1016\/j.ijcha.2020.100524_b0110","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"issue":"19","key":"10.1016\/j.ijcha.2020.100524_b0115","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/eurheartj\/ehz059","article-title":"Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial","volume":"40","author":"Oldgren","year":"2019","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcha.2020.100524_b0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ehjcvp\/pvz031","article-title":"Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis","volume":"6","author":"Galli","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"19","key":"10.1016\/j.ijcha.2020.100524_b0125","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/eurheartj\/ehy162","article-title":"Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials","volume":"39","author":"Golwala","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2020.100524_b0130","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2019.1880","article-title":"Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: A network meta-analysis of randomized controlled trials","author":"Lopes","year":"2019","journal-title":"JAMA Cardiol."},{"issue":"16","key":"10.1016\/j.ijcha.2020.100524_b0135","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMe1710753","article-title":"Triple therapy for atrial fibrillation after PCI","volume":"377","author":"Piccini","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijcha.2020.100524_b0140","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.amjcard.2017.12.014","article-title":"Meta-analysis comparing the safety and efficacy of dual versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"121","author":"Cavallari","year":"2018","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2020.100524_b0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11239-019-01874-1","article-title":"Dual versus triple therapy for patients with atrial fibrillation and acute coronary syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials","volume":"48","author":"Kheiri","year":"2019","journal-title":"J Thromb Thrombolysis."},{"issue":"2","key":"10.1016\/j.ijcha.2020.100524_b0150","doi-asserted-by":"crossref","first-page":"e000785","DOI":"10.1136\/openhrt-2018-000785","article-title":"Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis","volume":"5","author":"Brunetti","year":"2018","journal-title":"Open Heart"},{"issue":"14","key":"10.1016\/j.ijcha.2020.100524_b0155","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.jacc.2020.01.054","article-title":"Stent thrombosis with dual antithrombotic therapy in atrial fibrillation-ACS\/PCI Trials","volume":"75","author":"Galli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2020.100524_b0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ehjcvp\/pvy039","article-title":"Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: a jump with a weak parachute?","volume":"5","author":"Galli","year":"2018","journal-title":"Eur. Heart J. \u2013 Cardiovascul. Pharmacother."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906720300890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906720300890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:07:47Z","timestamp":1762492067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906720300890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":32,"alternative-id":["S2352906720300890"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2020.100524","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS\/PCI: A critical appraisal","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2020.100524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100524"}}